Clinical trial
Iodine-125 Brachytherapy Together With Chemotherapy Compared With Surgical Resection Followed by Concomitant Radiochemotherapy in Patients With Newly Diagnosed Glioblastoma，a Randomized, Open-label, Multi-center Clinical Trial
NCT04856852 is registered in ClinicalTrials.gov with The Affiliated Hospital of Qingdao University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Iodine-125 Brachytherapy Together With Chemotherapy Compared With Surgical Resection Followed by Concomitant Radiochemotherapy in Patients With Newly Diagnosed Glioblastoma，a Randomized, Open-label, Multi-center Clinical Trial
- Lead sponsor
- The Affiliated Hospital of Qingdao University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 28, 2021
- Completion date
- August 31, 2023
- Enrollment
- 84 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.